[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"anorexia-in-adolescence\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:anorexia-in-adolescence":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,64,99,123],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":35,"overallStatus":51,"whyStopped":4,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":63},"100648767","3-dimensional-optical-scanning-to-assess-and-monitor-malnutrition-in-eating-disorders-3d-ed-study-100648767",false,"NCT07726524","3-Dimensional Optical Scanning to Assess and Monitor Malnutrition in Eating Disorders (3D-ED) Study","3D-ED","Inclusion Criteria:\n\n* Diagnosis of anorexia nervosa (AN) or atypical anorexia nervosa (AAN), restricting or purging subtype, per DSM-5\n* Age 15 to 26 years\n* Medical instability warranting an inpatient hospitalization defined by either:\n\n  1. vital signs: daytime heart rate below 50 bpm or nighttime heart rate below 45 bpm, blood pressure below 90\u002F50 mm Hg, temperature below 36 C, orthostatic increase in heart rate above 20 bpm or decrease in systolic blood pressure above 20 mm Hg or decrease in diastolic blood pressure above 10 mm Hg from lying to standing, or median BMI below 75 percent; or\n  2. laboratory abnormality: AST above 40 IU\u002FL, ALT above 30 IU\u002FL, estimated GFR below 90 or cystatin C below 0.7 mg\u002FL, albumin below 3.7 g\u002FdL, or prealbumin below 20 mg\u002FdL\n* Extreme AN is defined as BMI below 15 kg\u002Fm2 or serious medical complications warranting admission to ACUTE (Denver Site).\n\nExclusion Criteria:\n\n* Bulimia nervosa\n* Another primary diagnosis causing malnutrition (not an eating disorder)\n* Current active suicidality\n* Metal implants or devices that interfere with study procedures","ALL","15 Years","26 Years",{"count":20,"type":21},90,"ESTIMATED","OBSERVATIONAL","People with anorexia nervosa often become medically unstable because of severe malnutrition and require hospitalization for nutritional rehabilitation. Clinicians currently rely heavily on body weight to assess malnutrition, but body weight does not always reflect the severity of illness. This study will use infrared scanning to assess body composition in adolescents and young adults hospitalized with anorexia nervosa. Researchers will then examine how organ and tissue stores relate to the degree of malnutrition, predict nutritional needs and medical restoration in hospital, and recovery outcomes over the following year. The goal is to develop more individualized approaches to nutritional rehabilitation and improve recovery for individuals with malnutrition due to eating disorders.",[25,26,27,28,29,30,31,32,33,34],"Anorexia in Adolescence","Anorexia Nervosa","Anorexia Nervosa, Atypical","Anorexia Nervosa, Binge Eating\u002FPurging Type","Anorexia Nervosa Restricting Type","Anorexia Nervosa With Significantly Low Body Weight","Body Composition Changes","Growth & Development","Malnutrition Severe","Malnutrition, Calorie",[36,37,38,39,40,41,42,43,44,45,46,47,48,49,50],"Organ residual mass","Body composition","Three-dimensional optical imaging","Optical body scanning","Refeeding","Refeeding syndrome","Nutritional rehabilitation","Resting energy expenditure","Eating disorders","Bioelectrical impedance analysis","Fat-free mass","Adolescent","Young adult","Anorexia nervosa","Growth charts","NOT_YET_RECRUITING","2026-07-22",{"date":54,"type":55},"2026-07-24","ACTUAL",{"date":57,"type":21},"2027-01",{"date":59,"type":21},"2031-05",{"name":61,"class":62},"University of California, San Francisco","OTHER",2,{"id":65,"slug":66,"hasResults":11,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":4,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":51,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":4},"100561684","fecal-microbiota-transplant-for-anorexia-nervosa-100561684","NCT06593366","Fecal Microbiota Transplant for Anorexia Nervosa","A Pilot Feasibility Randomized Controlled Trial of Fecal Microbiota Transplant for Adolescent Anorexia Nervosa","FMT-AN","Inclusion Criteria: All study subjects will have been diagnosed with AN (restricting type or binge eating\u002Fpurging type) by the primary physician on the ED team, as per standard approach. Study participants will:\n\n* Be 12-17 years-old at time of recruitment\n* Have capacity to consent\n* Be assigned female sex at birth (may be gender diverse)\n* Be active patients in the pediatric ED program at MCH\n* Have a weight that is \\\u003C85% of the Treatment Goal Weight, as determined by the treating physician\n\nExclusion Criteria: Potential study subjects will be excluded due to the following reasons:\n\n* Exposure to antibiotics within two weeks of study randomization\n* Initiation of new probiotics \u002F oral nutritional supplements within two weeks of randomization\n* Active pregnancy\n* Active psychosis or suicidal ideation\n* Other comorbidities that may affect weight or the gut microbiome including celiac disease, inflammatory bowel disease (or other conditions as determined by the study team)","FEMALE","12 Years","17 Years",{"count":76,"type":21},20,"INTERVENTIONAL",[79],"NA","The purpose of this pilot randomized-controlled trial is to determine whether Fecal Microbiota Transplant (FMT) treatment demonstrates feasibility, acceptability, and prelinary effectiveness among patients with anorexia nervosa (AN). Specifically, the investigators aim to compare changes in weight, gut microbiome, urine, blood biomarkers and mood symptoms between participants receiving the FMT intervention and placebo.",[29,26,25,82,83],"Anorexia in Children","Anorexia",[85,86,87,88,89],"anorexia nervosa","fecal microbiota transplant","pilot study","randomized controlled trial","feasibility","2026-05-22",{"date":92,"type":55},"2026-05-27",{"date":94,"type":21},"2026-06-01",{"date":96,"type":21},"2027-06-01",{"name":98,"class":62},"Hamilton Health Sciences Corporation",{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":4,"eligibilityCriteria":105,"healthyVolunteers":11,"sex":16,"minAge":106,"maxAge":107,"enrollmentInfo":108,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":110,"conditions":111,"keywords":4,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":122},"100457382","secretin-in-refeeding-100457382","NCT05235867","Secretin in Refeeding","Secretin Levels in Refeeding-induced Polyuria (Cross Section)","Inclusion Criteria:\n\n* Group 1:\n\n  * male and female patients\n  * age 13-24 years\n  * diagnosis of restrictive-type anorexia nervosa\n  * hospitalization for nutritional support\n  * \\>4 cc\u002Fkg\u002Fday of urine output (a.k.a. \"fluid dumpers\"; n=5)\n* Group 2:\n\n  * male and female patients\n  * age 13-24 years\n  * diagnosis of restrictive-type anorexia nervosa\n  * hospitalization for nutritional support\n  * \\\u003C2 cc\u002Fkg\u002Fd of urine output (a.k.a. \"non-dumpers\"; n=5)\n\nExclusion Criteria:\n\n* 5150 hold\n* Anti-depressant, anti-psychotic, or anticonvulsant medications\n* Previous hospitalization within the past 6 months\n* Underlying metabolic disorder not related to anorexia nervosa (including chronic kidney disease, renal tubular disorders, and underlying endocrine disorders)\n* Pregnancy\n* NG or G-tube feeds after day 2 of hospitalization\n* \\> 10% of nutritional needs from supplemental feeds","13 Years","24 Years",{"count":109,"type":21},10,"Patients with restrictive-type anorexia nervosa who are admitted to the hospital for feeding often urinate excessive amounts. Others have changes in the way that they handle acid and base. These issues prolong hospitalizations. Current data suggest that one hormone--named secretin--may control both urine output and how the body handles acid and base. This study will evaluate whether secretin levels are different in anorexic patients who urinate an excessive amount compared to those who urinate normal amounts. For this study, patients will have one extra blood draw before and after one meal during their hospitalization. The blood draw before the meal coincides with a standard of care blood draw. Also after the meal, subjects will be asked to provide one extra urine sample. Information from subject's medical records will also be used.",[25],"RECRUITING","2026-02-09",{"date":115,"type":55},"2026-02-12",{"date":117,"type":55},"2022-02-01",{"date":119,"type":21},"2027-12-31",{"name":121,"class":62},"University of California, Los Angeles",1,{"id":124,"slug":125,"hasResults":11,"nctId":126,"briefTitle":127,"officialTitle":127,"acronym":128,"eligibilityCriteria":129,"healthyVolunteers":11,"sex":16,"minAge":130,"maxAge":74,"enrollmentInfo":131,"targetDuration":4,"studyType":77,"phases":133,"briefSummary":134,"conditions":135,"keywords":136,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":141,"lastUpdatePostDateStruct":142,"startDateStruct":144,"completionDateStruct":146,"leadSponsor":147,"locationsCount":122},"100574447","family-based-telemedicine-vs-inpatient-anorexia-nervosa-treatment-fiat-100574447","NCT06759402","Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)","FIAT","Inclusion Criteria:\n\n* restrictive and bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01)\n* inpatient treatment indication according to S3 guideline\n* weight \\\u003C 3. BMI-percentile or\n* weight \\\u003C10. percentile and psychiatric comorbidity\u002Frapid weight loss\u002Flack of weight gain during outpatient treatment over last three month\n* planned inpatient treatment\n* insured with one of the participating health insurance companies\n* stable internet connection\n\nExclusion Criteria:\n\n* weight \\\u003C67%mBMI\n* acute self harm or danger to others\n* acute psychosis or suicidal tendencies\n* current substance abuse\n* child abuse or domestic violence in the family\n* insured with other health insurance company\n* judicial placement order for inpatient treatment\n* known, currently existing child protection problems or proceedings by the family court","8 Years",{"count":132,"type":21},200,[79],"The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.",[26,25],[137,138,139,140],"Psychotherapy","Family Based Treatment","RCT","Inpatient Treatment","2025-02-11",{"date":143,"type":55},"2025-02-13",{"date":145,"type":55},"2025-01-31",{"date":119,"type":21},{"name":148,"class":62},"Charite University, Berlin, Germany"]